欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2179/002
药品名称Vancomicina Kabi
活性成分
    • vancomycin hydrochloride 1000.0 mg
剂型Powder for infusion*
上市许可持有人Fresenius Kabi Pharma Portugal, Lda
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Greece (GR)
    • Germany (DE)
      Vancomycin Kabi 500 mg Pulver für eine Infusionslösung
    • Denmark (DK)
    • Belgium (BE)
      Vancomycine Fresenius Kabi
    • Iceland (IS)
    • Luxembourg (LU)
    • Ireland (IE)
    • Poland (PL)
      Vancomycin Kabi
    • Latvia (LV)
      Vancomycin Kabi 1000 mg pulveris infūziju šķīduma koncentrāta pagatavošanai
    • Lithuania (LT)
      Vancomycin Kabi 1000 mg milteliai infuzinio tirpalo koncentratui
    • Estonia (EE)
      VANCOMYCIN KABI 1000MG
    • Hungary (HU)
      VANCOMYCIN KABI 1000 mg por oldatos infúzióhoz való koncentrátumhoz
    • Bulgaria (BG)
      Vancomycin Kabi
    • Czechia (CZ)
      Vancomycin Kabi
    • Romania (RO)
      Vancomicina Kabi 1000 mg pulbere pentru concentrat pentru solutie perfuzabila
    • Slovakia (SK)
      Vancomycin Kabi 1 000 mg
    • Slovenia (SI)
      Vankomicin Kabi 500 mg in 1000 mg prašek za koncentrat za raztopino za infundiranje
    • France (FR)
许可日期2011/01/18
最近更新日期2024/04/16
药物ATC编码
    • J01XA01 vancomycin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase